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Abstract
Chronic kidney disease (CKD) and uremia increase the risk of heart disease
and sudden cardiac death. Coronary artery disease can only partly account for
this. The remaining mechanistic links between CKD and sudden death are elu-
sive, but may involve cardiac arrhythmias. For the present study, we hypothe-
sized that a thorough electrophysiological study in mice with CKD would
provide us valuable information that could aid in the identification of addi-
tional underlying causes of sudden cardiac death in patients with kidney dis-
ease. Partial (5/6) nephrectomy (NX) in mice induced mild CKD: plasma urea
in NX was 24  1 mmol/L (n = 23) versus 12  1 mmol/L (n = 22) in
sham-operated control mice (P < 0.05). Echocardiography did not identify
structural or mechanical remodeling in NX mice. Baseline ECG parameters
were comparable in conscious NX and control mice; however, the normal
24-h diurnal rhythm in QRS duration was lost in NX mice. Moreover, b-adre-
nergic stimulation (isoprenaline, 200 lg/kg intraperitoneally) prolonged QRS
duration in conscious NX mice (from 12  1 to 15  2 msec, P < 0.05), but
not in sham-operated controls (from 13  1 to 13  2 msec, P > 0.05). No
spontaneous arrhythmias were observed in conscious NX mice, and intracar-
diac pacing in anesthetized mice showed a comparable arrhythmia vulnerabil-
ity in NX and sham-operated mice. Isoprenaline (2 mg/kg intraperitoneally)
changed the duration of the QRS complex from 11.2  0.4 to 11.9  0.5
(P = 0.06) in NX mice and from 10.7  0.6 to 10.6  0.6 (P = 0.50) in
sham-operated mice. Ex vivo measurements of cardiac ventricular conduction
velocity were comparable in NX and sham mice. Transcriptional activity of
Scn5a, Gja1 and several profibrotic genes was similar in NX and sham mice.
We conclude that proper kidney function is necessary to maintain diurnal
variation in QRS duration and that sympathetic regulation of the QRS dura-
tion is altered in kidney disease.
Introduction
More than 20 million Americans are living with chronic
kidney diseases (CKD) and eight million of these have
moderate or severe CKD (Levey et al. 2003). Having
CKD places the patient at increased risk of sudden car-
diac death (Sarnak et al. 2003; Weiner et al. 2004; Pun
et al. 2009; Green and Roberts 2010; Herzog et al. 2011).
Twenty-seven percent of the all-cause mortality and two-
thirds of all cardiac death in dialysis patients are due to
cardiac arrhythmia and arrest (Poulikakos et al. 2014).
Coronary atherosclerosis is often found in patients with
CKD and is associated with a higher frequency of
arrhythmic death than in the general population (Herzog
et al. 2011). Nevertheless, dialysis patients undergoing
cardiac revascularization after myocardial infarction do
not have reduced probability of sudden cardiac death
compared to the population of dialysis patients as a
whole (Herzog et al. 2008). The conclusion from this
study was that despite coronary intervention, a large car-
diac mortality in dialysis patients remains present and the
mechanism for this is unknown. In support, statin
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treatment to reduce atherosclerotic events in patients with
CKD does not reduce risk of cardiac arrhythmic death
(Baigent et al. 2011). Thus, the increased risk of cardiac
arrhythmia in dialysis patients appears to be independent
of coronary artery disease.
The mechanistic link between CKD and cardiac arrhyth-
mias is multifactorial, including not only atherosclerotic
disease, but also autonomic and electrolyte imbalances,
hypertension, inflammation, and cardiac remodeling
(Green and Roberts 2010). Establishing potential links
between CKD and sudden cardiac death in animal models
has clear advantages, since such studies may guide subse-
quent discovery of potential new treatment modalities and
design of clinical trials. Rats with polycystic kidney disease
due to an inherited samcystin protein defect have severely
reduced glomerular filtration rate at 35 weeks of age and
elevated blood urea levels (Hsueh et al. 2014). Isolated
hearts from these rats show cardiac hypertrophy and
delayed repolarization. Importantly, the hearts isolated
from rats with kidney disease were more vulnerable to pac-
ing-induced arrhythmias (Hsueh et al. 2014). Contrary,
Donohoe and colleagues found increased repolarizing
potassium currents and faster repolarization in disaggre-
gated cardiomyocytes from rats with a surgically induced
renal failure (5/6 nephrectomy) (Donohoe et al. 2000a,b).
Thus, the findings on cardiac repolarization from the elec-
trophysiological examination in rodent models of chronic
renal disease are conflicting.
Mouse models of subtotal nephrectomy offer the advan-
tage of testing disease progression or severity. For example,
Bro et al. (2008) showed that 5/6 nephrectomy does not
change ventricular contractile function in apolipoprotein-
E-deficient mice. In the present study, we aimed to docu-
ment the cardiac electrophysiological effects of subtotal
nephrectomy in wild-type mice. We induced chronic kid-
ney disease by a two-stage 5/6 nephrectomy and compared
these to sham-operated control littermates. We recorded
and analyzed 24-h electrocardiograms from conscious mice
and performed cardiac electrophysiological investigations
in anesthetized mice and in isolated heart tissue.
Methods
General
The experiments performed in this study were approved by
the national ethics committee (Ministry of Environment
and Food, Denmark, permission no. 2013-15-2934-00773),
and conform to the European Parliament Directive on the
Protection of Animals Used for Scientific Purposes (2010/
63/EU). The experiments were carried out in accordance
with the guidelines made by the institutional and national
animal care and use committees. Male C57BL/6j Bom mice
(Taconic, Ejby, Denmark) were used in all experiments.
They were housed in groups in standard cages in an air-
conditioned room (21–23°C) with a 12-h light/dark sched-
ule, and had access to standard chow and water ad libitum.
Renal surgery to induce chronic kidney
disease
Uremia was induced in mice by 5/6 nephrectomy (NX) in a
two-step surgical procedure at 9–11 weeks of age (Fig. 1A).
Surgery was performed under general anesthesia (in lg/g
body weight administered subcutaneously (s.c.): tiletamin
16.3; zolazepam 16.3; xylazin 26.1; butorphanol tartrate
0.65). After induction of general anesthesia, a dorsal mid-
line incision was made and the left kidney was exposed
(sham) or resected after ligation of the renal vessels and the
ureter (NX) through a dorso-ventral incision in the mus-
cles and fascia. The muscle-fascial incision was closed using
4-0 suture, and the skin incision using 3-0 suture. One
week later, the upper and lower poles of the right kidney
were exposed (sham) or resected (NX) on all mice in a sim-
ilar procedure. Analgesia (buprenorphine 0.1 lg/g body
weight) was administered s.c. twice daily for up to 3 days
after the surgical procedures. Mice were numbered by ear
clippings, and investigators were blinded to whether the
mice were nephrectomized or sham-operated.
Echocardiography
Transthoracic echocardiography was performed 8–9 weeks
after renal surgery with a linear 30-MHz transducer
(VisualSonics, Toronto, Canada) at an axial resolution of
55 lm and a lateral resolution of 115 lm. Each mouse
was anesthetized with 2% isoflurane in a mix of O2 and
N2 (30:70) and placed in a supine position on a heated
table. Posterior and anterior wall thickness and left ven-
tricular inner diameter (LVID) were determined at systole
(s) and diastole (d) from M-mode parasternal short-axis
and long-axis views. Left ventricular end-diastolic and
end-systolic volumes (EDV and ESV, respectively) were
estimated from LVID according to the algorithm of the
manufacturer. Stroke volume (SV = EDV  ESV), ejec-
tion fraction (EF = SV/EDV), and fractional shortening
(FS = (LVIDd  LVIDs)/LVIDd) were calculated.
Radiotelemetry recording of ECG and
b-adrenergic challenge
Radiotransmitter telemetry devices (ETA-F10, Data
Sciences International, St. Paul, MN) were implanted in
anesthetized mice (2% isoflurane in 100% O2) subcuta-
neously on the dorsal area between the scapulae, as previ-
ously described (Gottlieb et al. 2017). Postoperative
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analgesia included carprofen (10 mg/kg, s.c.), lidocaine,
and bupivacain (0.4 and 1.0 mg/kg, respectively, in the
s.c. pocket). Electrocardiograms (ECG) were recorded
continuously at 1 kHz for 24 h in freely moving and
conscious mice >7 days after surgery using a setup previ-
ously described (Gottlieb et al. 2017). The mice were in
their normal 12-h light/dark schedule, and had access to
food and water ad libitum during the recordings. After
24-h, a single dose of isoprenaline (200 lg/kg) was
administered intraperitoneally and the electrophysiologi-
cal effects were recorded for 30 min. ECGs were analyzed
every hour and the diurnal rhythms of the electrophysio-
logical parameters were described by a cosinor fit to the
data. Heart-rate variability was quantified according to
the recommendations by Thireau and colleagues (Thireau
et al. 2008).
Invasive electrophysiological study
Mice were anesthetized using 2% isoflurane in a mix of
O2 and N2 (30:70) and a standard 6-lead surface ECG
was recorded for 10 min before any surgery (LabChart,
ADInstruments, Australia). Body temperature was moni-
tored and kept at 36–38°C during the entire procedure.
The right jugular vein was isolated via a small opening of
the skin on the frontal neck region, and a 1.1 F octal
polar pacing catheter was inserted and advanced to the
right ventricle via the right atrium. Pacing stimuli
(1 msec duration) were provided by an external stimula-
tor (DS3, Digitimer, Welwyn Garden City, UK) con-
trolled by LabChart software and delivered at the
endocardium of the right ventricle. ECGs from anes-
thetized and conscious mice were analyzed as described
60 mice
15 †
NX, n = 23    Sham, n = 22
Echocardiography:
NX, n = 6    Sham, n = 6
ECG telemetry:
NX, n = 10    Sham, n = 9
Cardiac pacing:
NX, n = 8    Sham, n = 8
Conduction velocity:
NX, n = 6    Sham, n = 8
* *
A
B
Figure 1. (A) Male mice were subjected to 5/6 nephrectomy (NX) or sham operation. A period of 8–9 weeks later, echocardiography, ECG
telemetry, cardiac pacing, and conduction-velocity measurements were performed on the indicated number of mice. Some, but not all mice
were used for more than one test. (B) Plasma markers of kidney function, urea, and creatinine, were measured in plasma samples taken from
NX (black circles) and sham-operated (white circles) mice at the termination of the study. *P < 0.05 (Student’s t test).
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previously (Speerschneider and Thomsen 2013; Speer-
schneider et al. 2013).
Excitation threshold was determined by gradually increas-
ing current amplitude until cardiac capture. Subsequent
pacing was performed at four times capture threshold. After
a 5-min recording period in spontaneous sinus rhythm, we
paced the right ventricle for 2 min at a constant cycle length
of 80 msec. Effective refractory period of the ventricles was
determined using an S1–S2 protocol, where 10 S1 stimuli
with 100-msec interpulse interval was followed by a single
S2 stimulus where the S1–S2 interval was increased from 20
to 80 msec in steps of 1 msec. Arrhythmia vulnerability was
assessed using a modified S1–S2 protocol with six times S2
stimuli. Burst pacing at 50 Hz for 1 sec was also used to test
arrhythmia risk. After one round of pacing, isoprenaline
(2 mg/kg) was administered intraperitoneally and the pac-
ing was repeated. At the end of the experiments, a blood
sample was taken and the heart was explanted for ex vivo
experiments. The mice used in the invasive study were dif-
ferent from the mice used in the experiments employing
radiotelemetry recordings of the ECG in conscious mice.
Biochemical measurements
Blood was collected in heparinized microtubes and cen-
trifuged at 1500 g for 10 min at 4°C. Plasma concentrations
of urea, creatinine, phosphate, and calcium were measured
on a Cobas 8000 modular analyzer series (Roche, Denmark).
Ex vivo measurement of conduction velocity
Conduction velocity was measured essentially as described
for rat atrial tissue previously (Olsen et al. 2011). In
short, a longitudinal strip of the right ventricular free wall
was isolated. A loop was sutured in each end of the strip
and mounted in a 1-mL chamber, perfused at 2 mL/min
with a solution containing (in mmol/L): NaCl 136, KCl 4,
MgCl2 0.8, CaCl2 1.8, HEPES 5, MES 5, Glucose 10, pH
7.4 and equilibrated with 100% O2. The remainder of the
heart was snap frozen in liquid N2 and stored at 80°C
until further analysis.
Strips were stimulated at the apical end with a unipolar
electrode at 5 Hz (duration 0.5 msec and double thres-
hold) and local activation was detected at two points
using platinum/iridium electrodes (PI20030.5B10, Micro
Probe Inc., Gaithersburg, USA) connected to two Iso-
DAM8A amplifiers (World Precision Instruments, Sara-
sota, USA). Signals were band-pass filtered (0.3–10 kHz)
and sampled at 30 kHz (Digidata 1322A, Axon Instru-
ments, Union City, USA). Interelectrode distance was
measured using a microscope with an ocular grid (Wild
M38, Heerburg, Switzerland). Time of local activation
was determined by a custom written script in MATLAB
and conduction velocity was calculated as electrode dis-
tance divided by interelectrode delay.
Gene-expression studies
The heart was quickly thawed in 0.9% saline and a 1-mm
wide transmural strip from the left ventricular free wall
was excised. RNA was extracted using the Trizol reagent
as previously described (Pedersen et al. 2013). cDNA was
constructed from 500 ng RNA using the High Capacity
cDNA Reverse Transcription kit according to the manu-
facturer’s instructions (Applied Biosystems). Two ng
cDNA was used for quantitative RT-PCR analyses.
Standard real-time PCR using the fast SYBR green master
mix (Applied Biosystems) was used to quantify expression of
Bgn (encoding biglycan), Col1a1 (procollagen-1), Mrc1 (en-
coding the macrophage-specific mannose receptor, CD206),
and the housekeeping gene Hprt (hypoxanthine phosphori-
bosyltransferase). Primer sequences were: Bgn, forward: 50-G
TGGTCCAGGTGAAGTTCGT-30, reverse: 50-ACAACCGTA
TCCGCAAAGT-30; Col1a1, forward: 5-GAGCGGAGAGTA
CTGGATCG-30, reverse: 50-GCTTCTTTTCCTTGGGGTT
C-30; Mrc1, forward: 5- TCGCCCACCAGAGCCCACAA-30,
reverse: 50-ATGCTCGCCAGCTCTCCACCT-30; Hprt, for-
ward: 50-TTGCGCTCATCTTAGGCTTT-30, reverse: 50-AAG
CTTGCTGGTGAAAAGGA-30. For quantification of Scn5a,
Gja1 and Hprt expression, we used predesigned probes:
Mm00439105_m1 (Gja1), Mm01342518_m1 (Scn5a), and
Mm00446968_m1 (Hprt). All reactions were run in accor-
dance with the manufacturer’s instructions. For both primer
and probe reactions, expression of target genes was normal-
ized to the expression of Hprt, run either as a primer or as a
probe reaction, as detailed.
Statistical analysis
All results are expressed as mean  SEM. Differences
between groups were statistically tested by unpaired Stu-
dent’s t test; whereas differences within groups as result
of drug administration were tested using a paired Stu-
dent’s t test. Effects of isoprenaline in the two groups of
mice were statistically compared using a two-way repeated
measures analysis of variance (ANOVA) with a Bonfer-
roni post hoc t test when appropriate. Arrhythmia inci-
dences were compared using a Fisher’s exact test. P values
<0.05 were considered statistically significant.
Results
Development of mild uremia secondary to
5/6 nephrectomy
In total, 60 mice underwent either 5/6 nephrectomy or
sham operations. Of these, 45 mice survived up to
2018 | Vol. 6 | Iss. 13 | e13720
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9 weeks until experiments (Fig. 1A). Body weights at the
end of the study period were significantly smaller in NX
mice (28  1 g, n = 14) compared to sham-operated
mice (32  1 g, n = 14; P < 0.01). Plasma contents of
urea and creatinine were increased in NX mice (Fig. 1B).
The concentration of calcium in the plasma was also
increased in NX mice (2.8  0.1 mmol/L vs. sham:
2.4  0.1 mmol/L; P < 0.01). These data are compatible
with a relatively mild uremic condition following 9 weeks
of markedly reduced kidney mass, and they are compara-
ble to earlier data from us (Madsen et al. 2017).
No structural or mechanical remodeling of
the heart in NX mice
Structural and mechanical remodeling was assessed by ultra-
sound 8–9 weeks after nephrectomy or sham operations
(Fig. 2A). Left ventricular inner diameter was comparable
in both systole and diastole (Fig. 2B). In addition, left ven-
tricular wall thickness was comparable in NX and sham
mice in both systole and diastole (Fig. 2C). From these
structural measurements, several mechanical indexes are
estimated by the software algorithms, e.g., ejection fraction
(NX: 59.8  1.9 vs. sham: 60.0  2.1%; P = 0.95) and frac-
tional shortening (NX: 31.6  1.4 vs. sham: 31.8  1.4%;
P = 0.91). During these recordings, RR intervals were com-
parable in the two groups of mice (NX: 478  13 vs. sham:
472  22; P = 0.81). Thus, uremia does not cause struc-
tural or mechanical cardiac remodeling in mice.
Prolonged ventricular activation time in
conscious, uremic mice after isoprenaline
administration
To describe potential electrical remodeling in the uremic
mice, we recorded a 1-lead ECG for 24 h. Exemplary
ECG traces are shown in Figure 3A. No arrhythmias
apart from single, spontaneous premature ventricular
contractions were identified in either NX or sham ani-
mals during the 24-h recording. We did not identify any
statistically significant electrophysiological differences
between the 24-h mean of the data from NX and sham
mice (Table 1), although the P value for the statistical
comparison of the RR intervals was low (110  3 vs.
117  2 msec in NX and sham, respectively; P = 0.054).
The amplitude of the 24-h rhythm in RR (Fig. 3B), PR
(not shown) and QT intervals (Fig. 3D) were depressed
in NX mice. Interestingly, it was not possible to fit a
cosinor function to the QRS interval data from NX mice
(Fig. 3C), suggesting that the natural 24-h rhythm in
QRS intervals was eliminated. The acrophase of the fit,
indicating the temporal location of the peak of the elec-
trophysiological parameter was not different in NX and
sham-operated mice.
NX Sham
100 ms
1 ms
LVID
AWT
PWT
A
B C
Figure 2. (A) Representative M-mode echocardiographic images from the left ventricle in anesthetized mice. AWT; anterior wall thickness; LVID:
left ventricular inner diameter; PWT: posterior wall thickness. (B) Left ventricular inner diameter in diastole and systole for NX and sham mice.
Diastolic diameter is significantly larger than systolic diameter for both mice groups (not indicated); however, there is no difference between NX and
sham. (C) Left ventricular wall thickness (mean of anterior and posterior wall) in diastole and systole for NX and sham mice. Systolic wall thickness is
significantly larger than diastolic wall thickness for both mice groups (not indicated); however, there is no difference between NX and sham.
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To quantify heart-rate variability, we identified all R
waves during the 24-h recording period. The standard
deviation of the RR intervals and the standard deviation
of successive RR interval differences between adjacent RR
intervals were comparable in NX and sham mice. The
percentage of successive RR interval differences longer
than 6 msec (pRR6, (Thireau et al. 2008)) was 16  2%
in NX mice and 21  3% in sham mice (P = 0.32).
After the 24-h recording, the mice received an
intraperitoneal bolus injection of the b-adrenergic recep-
tor agonist, isoprenaline. Two NX mice had sustained
sinoatrial-node-related arrhythmias with intermittent
acceleration and sinus-node block without P waves after
isoprenaline, and were excluded from analysis. This
arrhythmia incidence was not significantly different from
the arrhythmia-free sham-operated mice (Fisher’s exact
test). RR intervals shortened as expected after b-adrener-
gic receptor stimulation and this was comparable in NX
and sham mice (Fig. 4A). Interestingly, QRS duration
prolonged significantly in NX mice only, compared to
sham mice (Fig. 4B and C). Overall, the QRS duration
prolonged by 36  14% in NX mice (from 12.1  1.2 to
15.3  1.9 msec; P < 0.05), but only by 7  7% in sham
NX
Sham
100 ms
P
QRS T
A B
C D
Figure 3. (A) Representative ECG traces from conscious NX and sham mice. P wave, QRS complex, and T wave are indicated on the first complex.
(B) RR intervals during 24 h in NX and sham mice. The light was on from 6 AM to 6 PM (0–12 h on the abscissa, indicated by a white box) and off
from 6 PM to 6 AM (12–24 h on the abscissa, indicated by a black box). The indicated fits are from a three-parameter cosinor function with a fixed
phase of 24 h. We tested the probability of an amplitude of zero (i.e., no 24-h rhythm), and plotted the fit only if P < 0.05. The amplitude of the
fit, i.e., from mean to peak, is indicated on the graph. *P < 0.05 versus the amplitude of the NX fit. (C) QRS intervals during 24 h. Details as in
panel B. There was no 24-h rhythm of QRS complexes in NX mice. (D) QT intervals during 24 h. Details as in panel B.
Table 1. Analysis of ECG from conscious mice.
NX Sham P value
N, mice 10 9 –
RR interval, msec 110  3 117  2 0.054
PR interval, msec 37  1 38  1 0.39
QRS interval, msec 13.1  0.4 12.7  0.3 0.50
QT interval, msec 53  1 52  2 0.61
P values from a Student’s t test.
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mice (from 12.8  1.9 to 13.1  2.1 msec; not statisti-
cally significant). The between-groups comparison, assess-
ing QRS duration after isoproterenol, also showed a
significantly longer QRS duration in NX mice (P < 0.05).
To analyze this in detail and to determine the potential
consequences, we performed an invasive electrophysiolog-
ical study in anesthetized uremic and control mice.
Anesthesia masks electrophysiological
differences between NX and sham-operated
mice
We recorded 6-lead surface ECGs in anesthetized NX and
sham mice and the results are presented in Table 2. In the
unstressed situation, we observed no differences between
the two groups of mice, which confirm our findings from
the conscious mice. Pacing constantly from the right ven-
tricle at a cycle length of 80 msec produced a prolongation
of the QRS complex in both NX and sham mice (to 21  1
and 21  1 msec, respectively; P = 0.75; Fig. 5). Electrical
pacing to induce cardiac arrhythmia elicited short runs of
ventricular tachycardia in 3/8 NX mice and 2/8 sham-oper-
ated mice (P = 1.00, Fisher’s exact test).
Intraperitoneal administration of isoprenaline caused a
shortening in RR intervals in both NX (from 104  4
to 95  2 msec; P < 0.001) and sham-operated mice
(from 100  2 to 90  1 msec; P < 0.001, two-way
ANOVA). Simultaneously, the duration of the QRS
A
RR
 in
te
rv
al
, m
s
Time, min
C
Q
RS
 in
te
rv
al
, m
s
Time, min
B
Isoprenaline Isoprenaline
QRS: 11 ms QRS: 16 ms QRS: 12 ms QRS: 13 ms
*
NX, control Sham, isoprenalineSham, controlNX, isoprenaline
Figure 4. (A) RR intervals measured every minute before and after isoprenaline administration in conscious mice. (B) QRS intervals measured
every minute before and after isoprenaline administration in conscious mice. * indicates a statistically significant difference between NX and
sham-operated mice based on a two-way ANOVA on all postadministration data points. (C) Representative ECG traces from conscious NX and
sham-operated mice, before and after isoprenaline administration. Note the change in QRS morphology after isoprenaline in the NX mice,
causing an overall prolongation of the QRS duration.
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complex changed from 11.2  0.4 to 11.9  0.5
(P = 0.06; Fig. 5B) in NX mice and from 10.7  0.6 to
10.6  0.6 (P = 0.39) in sham-operated mice. The QRS
duration was not significantly longer in NX mice com-
pared to sham-operated mice after isoprenaline
(P = 0.2). Pacing to induce cardiac arrhythmias after
administration of isoprenaline produced short runs of
ventricular tachycardia in 5/8 NX mice and in 3/8
sham-operated mice (P = 0.61). Pacing the heart 5 min
after administration of isoprenaline prolonged the QRS
complex in both NX and sham mice; however, to dura-
tions comparable to pacing without adrenergic stimula-
tion (Fig. 5B). Based on these findings, we decided to
test conduction velocity ex vivo.
Ex vivo measurement of conduction velocity
is comparable in NX and sham-operated
mice
To explore the role of conduction in the observed QRS
prolongation, we acutely isolated right ventricular strips
from sham (n = 8) and NX mice (n = 6). On average,
conduction velocity was 0.81  0.07 m/sec for NX mice
and 0.82  0.05 m/sec for sham-operated mice
(P = 0.89; Fig. 6). Next, we stimulated the strips with iso-
prenaline (0.3 lmol/L) followed by a washout phase. A
two-way ANOVA indicated no significant effect of either
mouse group, treatment or their interaction.
No difference in the expression of key
genes controlling conduction velocity
To determine whether the prolonged QRS complexes after
uremia were corroborated by fibrotic changes in the
heart, we performed gene-expression analyses on RNA
extracted from the left ventricle. mRNA expression of the
profibrotic genes, biglycan, procollagen-1, and CD206 (a
marker of profibrotic M2-like macrophages) was similar
in hearts from NX and sham-operated mice. Likewise,
mRNA expression of the cardiac voltage-gated sodium
channel (SCN5A) and the gap-junction protein connexin
43 (GJA1) was not altered in the left ventricle from ure-
mic as compared to sham mice (Fig. 7).
Discussion
In summary, the present characterization of the cardiac
electrophysiological consequences of CKD shows a sur-
prisingly small cardiac impact of 5/6 nephrectomy. Struc-
tural and mechanical properties are comparable (Fig. 2)
as are electrophysiological parameters at first glance
(Tables 1 and 2). Only a disappearance of the 24-h oscil-
lation of the QRS interval duration (Fig. 3C) and an
unanticipated prolongation of the QRS interval after
b-adrenergic receptor stimulation (Fig. 4B) in conscious
NX mice are identified in the present study. There is a
trend toward prolongation of the QRS complex in anes-
thetized NX mice after b-adrenergic receptor stimulation
(Fig. 5B); however, ex vivo determination of conduction
velocity and analysis of expression of key genes encoding
proteins implicated in conduction and fibrosis provide no
underlying mechanism.
Cardiac remodeling in animals with CKD
A rat model of CKD based on spontaneous cystic kidney
disease due to an inherited samcystin protein defect has
moderately elevated plasma urea levels (Hsueh et al.
2014), comparable to the levels shown in Figure 1A.
(Note: The correct unit of blood urea nitrogen in Table 1
of reference (Hsueh et al. 2014) is probably mg/mL, not
mg/L). In apparent conflict with our findings, Hsueh
et al. (2014) find a marked ventricular hypertrophy of the
hearts in rats with samcystin defect, although heart rate
and cardiac pump function (e.g., ejection fraction) are
comparable, as in our data. Cardiac hypertrophy has also
been reported in another rat model of CKD due to partial
nephrectomy (Donohoe et al. 2000a).
Comparable to our findings in mice, the samcystin-
deficient rats with CKD have unaltered refractory period
and conduction velocity, and they have a normal fre-
quency of spontaneous ventricular contractions in vivo
(Hsueh et al. 2014). Notwithstanding, the hypertrophic
hearts from the rats with CKD showed a statistically sig-
nificant increased vulnerability to pacing-induced arrhyth-
mia in an isolated heart preparation (Hsueh et al. 2014),
and a later study in the same rats showed that they die
spontaneously after a preceding 24-h period with a con-
tinuous decline in heart rate (Zhao et al. 2016). In the
Table 2. Analysis of ECG from anesthetized mice.
NX Sham P value
N, mice 8 8 –
RR interval, msec 112  5 114  3 0.74
PR interval, msec 37  1 39  1 0.47
QRS interval, msec 10.9  0.5 10.7  0.4 0.78
QT interval, msec 50  2 50  2 0.99
J-wave amplitude, lV 125  15 122  18 0.87
T-wave amplitude, lV 23  33 25  9 0.97
Lead II was analyzed. The large SEM for T-wave amplitude reflects
that T waves presented both with positive and with negative
amplitude in both NX (5 positives, 3 negatives) and sham mice (7
positives, 1 negative). J-wave amplitude was always positive. P val-
ues from a Student’s t test.
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present study, we were not able to confirm increased
arrhythmia susceptibility in CKD, when pacing the hearts
in situ in the intact animal.
Disaggregated cardiomyocytes from rats isolated 8 weeks
after 5/6 nephrectomy have larger repolarizing potassium
currents and the action potentials are significantly shorter
(Donohoe et al. 2000a,b), whereas cardiomyocytes from
rats with 8 weeks of unilateral nephrectomy have smaller
repolarizing potassium currents and longer action poten-
tials (Lee et al. 2017). This appear to be in contrast to our
present findings of unaltered QT intervals in vivo (Table 1
and 2) and to the data from Hsueh et al. (2014); however,
the underlying mechanism for these differences cannot be
ascertained by the data from the present study.
Fontes and colleagues report that 5/6 nephrectomy in
mice cause increased plasma urea comparable to the pre-
sent data. In an isolated heart preparation, they are able
to induce ventricular arrhythmias in two of eight hearts,
which is comparable to the data from our invasive study
(five of eight mice with pacing-induced arrhythmias;
NX
ECG
EGM
Sham
ECG
EGM
Stim
Stim
Control PacingIsoprenaline Iso + pacing
200 ms
P = 0.06
A
B
Figure 5. (A) Representative surface electrocardiograms (ECG) and intracardiac electrogram (EGM) from an NX and a control mice. Stimulus
(stim) indicates right ventricular apex pacing. Mice were paced before and after administration of isoprenaline. Arrow points to the His
potential on the EGM. (B) QRS duration in NX and control mice during normal sinus rhythm (no pacing) and during ventricular pacing, before
and after administration of isoprenaline. Ventricular pacing causes a twofold prolongation of the QRS interval that was comparable in both
mice groups. There is a trend toward a statistically significant isoprenaline-induced prolongation of the QRS complex in NX mice (P = 0.06), but
not in sham-operated mice (P = 0.50).
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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P = 0.3 from Fisher’s exact test). Furthermore, these mice
show no signs of cardiac hypertrophy. The authors fur-
ther challenge the NX mice with a high-salt diet, which
increases urine albumin content; however, this does not
significantly alter arrhythmia burden (Fontes et al. 2015).
Thus, it appears that isolated hearts from mice (Fontes
et al. 2015) or rats (Hsueh et al. 2014) with CKD are
prone to ventricular pacing-induced arrhythmias, and the
proposed mechanisms are diverse and may be influenced
by model, strain, and species differences. To the best of
our knowledge, the present study is the first to show that
mice with CKD are not susceptible to spontaneous or
pacing-induced cardiac arrhythmias in vivo. It should be
emphasized that testing the electrophysiology of the heart
in vivo in the setting of CKD has the important advan-
tage that uremic toxin exposure and potential electrolyte
imbalances are intact.
Altered QRS complex in CKD mice
We have previously documented the presence of a 24-h
rhythm of the QRS complex in conscious wild-type
mice (Gottlieb et al. 2017). The control mechanism of
such 24-h rhythm can reside in (1) the endogenous
cardiac clock, using a transcription-based mechanism
(Martino and Young 2015); (2) an endogenous clock of
another cell type or organ that provides a neurohu-
moral signal to the heart; or (3) by the central clock
in the suprachiasmatic nucleus of the brain, where
environmental cues entrain the master clock controlling
all the peripheral organ clocks (Buhr et al. 2010). For
example, disaggregated cells isolated from the heart and
cultured show clear circadian rhythms in gene expres-
sion of clock genes (Durgan et al. 2005), and cardiomy-
ocyte-specific knockout of key clock genes leads to
Figure 6. Conduction velocity in isolated right ventricular strips from NX and sham-operated mice. Measurements were performed at baseline,
under isoprenaline stimulation and after washout.
Figure 7. NX does not affect mRNA expression of select genes in the left ventricle of the heart. mRNA expression analyses of the fibrotic
genes biglycan and procollagen-1, the M2 macrophage marker CD206, the voltage-gated sodium channel scn5a, and the gap-junction protein
gja1 in the left ventricle of the heart. For each gene, the relative expression (in arbitrary units, a.u.) was determined and normalized to the
housekeeping gene hypoxanthine-guanine phosphoribosyltrasferase (HPRT). One outlying data point of Gja1 expression in one NX mouse was
excluded from analysis.
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spontaneous heart failure (Young et al. 2014; Ingle
et al. 2015). It is presently unknown what causes the
24-h oscillation of the QRS complex; however, a
rhythm in both Cx43 expression in the heart (Pizarro
et al. 2013) and in SCN5A expression (Schroder et al.
2013) have been reported. It is unclear how NX could
directly blunt the rhythm of expression of a gene in
the heart, but it is tempting to speculate that the
healthy kidney produces a signal with a 24-h rhythm
that modulates the QRS complex of the heart, and that
this rhythm is lost in CKD. The signal may be a neu-
rohumoral or it may simply be an oscillation of elec-
trolyte concentrations in the plasma secondary to
circadian rhythmicity in kidney function (Firsov et al.
2012; Sennels et al. 2012). This hypothesis would be in
apparent agreement with the comparable conduction
velocities we observe ex vivo (Fig. 6), where this signal
would be lost or identical in both NX and sham prepa-
rations. The QRS duration increases in humans under-
going hemodialysis (Morales et al. 1998; Drighil et al.
2008; Tarif et al. 2008; Berta et al. 2012; Astan et al.
2015; Ozportakal et al. 2017), indicating that severe
CKD causes an accumulation of one or more elusive
factors that shorten QRS duration.
The QRS duration prolonged significantly in con-
scious NX mice challenged acutely with isoprenaline
(Fig. 4). Moreover, in anesthetized mice, the isopre-
naline-induced increase in QRS duration was blunted
and did not reach statistical significance (P = 0.06;
Fig. 5B). Thus, it appears that isoflurane anesthesia may
conceal the effect of isoprenaline on the QRS complex
in NX mice, which may be related to an apparent short-
ening of the QRS complex under isoflurane anesthesia
(comparing Tables 1 and 2). One significant caveat of
comparing the two tables is that the data come from
different mice and different ECG leads. Isoprenaline
administration to conscious mice was performed during
the light phase, where QRS duration was comparable
between NX and sham-operated mice (Fig. 3C), and the
effects of isoprenaline may be different during the dark
phase, where the QRS duration is shorter in the sham-
operated mice. In both anesthetized and conscious mice,
the isoprenaline challenges were performed during the
light phase.
Severe hypercalcemia is associated with QRS prolonga-
tion, and it is a possibility that the small increase in the
concentration of calcium in the plasma of the NX mice
may have contributed to the longer QRS duration in
these mice. In the present study, we did not measure
plasma concentrations of sodium, potassium or any
humoral factors from the kidney, and it is presently
unclear what underlies the increased QRS duration after
isoprenaline in NX mice.
Clinical perspectives
Ventricular arrhythmias are relatively common in patients
with CKD and the reason for this is unknown (Green
and Roberts 2010). The present detailed documentation
of the cardiac electrophysiological effects of subtotal
nephrectomy in intact, conscious mice suggests that the
heart is not affected by mild uremia in mice. Notwith-
standing, imbalances in neurohumoral, electrolyte or cir-
cadian systems imposed by the failing kidney may acutely
change the electrophysiological parameters of the heart.
Conclusions
Mild, chronic kidney disease does not give rise to a struc-
tural or mechanical phenotype in mice. Electrophysiologi-
cally, we identify a loss of the 24-h diurnal rhythm in
QRS duration and an unexpected prolongation of the
QRS interval after b-adrenergic receptor stimulation.
These effects are only present in vivo, and ex vivo
attempts to pinpoint the mechanism failed to do so. We
conclude that normal kidney function is necessary to
maintain diurnal variation in QRS duration of the heart,
and that sympathetic regulation of the QRS duration is
altered in kidney disease.
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